A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis

Clinical trial NCT03282318 · COMPLETED

Trial details

NCT number: NCT03282318
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Pain Syndrome Interstitial Cystitis

Start date: 2017-09-28
Primary completion: 2019-03-21
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.